Patent details

300919 Product Name: Brodalumab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300919
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2076541
Status:
SPC granted but not yet in force
Application number:
300919
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/16/1155
Marketing Authorization Type:
EEA
Marketing Authorization Date:
19/07/2017
Marketing Authorization Country:
European Patent Office (EPO) (EP)

Dates

Filing date:
15/12/2017
First Marketing Authorization date:
19/07/2017
Grant date:
11/04/2018
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
20/12/2017
SPC/SPC Extension Expiration Date:
18/07/2032
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
15/12/2017
 
 

 

Name:
Kirin-Amgen, Inc.
Address:
One Amgen Center Drive, THOUSAND OAKS CA 91320-1799, United States of America (US)

Agent

Name:
ir. H.A. Witmans c.s.
From:
15/12/2017
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
16/18
Publication date:
11/04/2018
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
51/17
Publication date:
20/12/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
30/09/2027
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
11/04/2018 SPC Documents Certificate SPC 1 PDF /2/0/1/6/2/0800226102/docs/300919_0_supplprotectioncertificate20180411103448787.pdf
11/04/2018 Outgoing Correspondence Outgoing Letter 1 PDF /2/0/1/6/2/0800226102/docs/300919_6_outgoingcorrespondence20180411103448697.pdf
06/04/2018 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /2/0/1/6/2/0800226102/docs/300919_3_incomingcorrespondencepaper20180409121727612.pdf
16/02/2018 Outgoing Correspondence Outgoing Letter 2 PDF /2/0/1/6/2/0800226102/docs/300919_8_outgoingcorrespondence20180216022056752.pdf
21/12/2017 Outgoing Correspondence Confirmation receipt request 1 PDF /2/0/1/6/2/0800226102/docs/300919_1_183014l174.pdf
18/12/2017 SPC Documents Annex SPC 18 PDF /2/0/1/6/2/0800226102/docs/300919_2_supplprotectioncertificate20171220123708779.pdf
18/12/2017 SPC Documents Marketing Authorization SPC 3 PDF /2/0/1/6/2/0800226102/docs/300919_4_supplprotectioncertificate20171220123708385.pdf
18/12/2017 SPC Documents Summary of the characteristics of the product 14 PDF /2/0/1/6/2/0800226102/docs/300919_5_supplprotectioncertificate20171220123708511.pdf
18/12/2017 Application Form First filed application form 3 PDF /2/0/1/6/2/0800226102/docs/300919_7_applicationform20171220123708098.pdf
18/12/2017 SPC Documents Annex SPC 2 PDF /2/0/1/6/2/0800226102/docs/300919_9_supplprotectioncertificate20171220123708640.pdf